GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » XCounter AB (OSTO:XCT) » Definitions » Research & Development

XCounter AB (OSTO:XCT) Research & Development : kr0.00 Mil (TTM As of Dec. 2012)


View and export this data going back to . Start your Free Trial

What is XCounter AB Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. XCounter AB's Research & Development for the three months ended in Dec. 2012 was kr0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2012 was kr0.00 Mil.

XCounter AB Research & Development Historical Data

The historical data trend for XCounter AB's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XCounter AB Research & Development Chart

XCounter AB Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12
Research & Development
Get a 7-Day Free Trial Premium Member Only - - - - -

XCounter AB Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12
Research & Development - - - - -

XCounter AB Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XCounter AB  (OSTO:XCT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XCounter AB Research & Development Related Terms

Thank you for viewing the detailed overview of XCounter AB's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

XCounter AB (OSTO:XCT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » XCounter AB (OSTO:XCT) » Definitions » Research & Development
Comparable Companies
XSAT:ISAB MICR XSAT:NEOD OSTO:ACARIX XSAT:OBST LSE:CPT XTAE:MDGS ALRT DYNT DRAD HLTY XCNQ:ASTI XTAE:EMITF XCNQ:IME ASX:SVA LSE:DEMG ROCO:4198 XSAT:MPOS WCUI OSTO:ADDV A
Traded in Other Exchanges
N/A
Address
Website

XCounter AB (OSTO:XCT) Headlines

No Headlines